Completed PHASE3 INTERVENTIONAL 3-arm NCT01309113

Dose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome

Double-blind Comparison of VAC BNO 1095 Film Coated Tablets With Placebo to Identify Dose Dependent Effects in Patients Suffering From Cyclic Mastodynia and Premenstrual Syndrome

Sponsor: Bionorica SE

Conditions Cyclic Mastodynia Premenstrual Syndrome

Interventions VAC BNO 1095 film coated tablets

Updated 6 times since 2017 Last updated: Jul 8, 2013 Started: Mar 31, 2011 Primary completion: Jan 31, 2012 Completion: Nov 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cyclic Mastodynia and Premenstrual Syndrome and is currently completed. Bionorica SE leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bionorica SE

Data source: Bionorica SE

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Olomouc, Czechia